BlackRock, Inc. 13D and 13G filings for Gilead Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-24 09:27 am Sale | 2025-03-31 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 101,739,273 8.200% | -21,051,024 (-17.14%) | Filing |
| 2024-01-24 2:27 pm Sale | 2023-12-31 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 122,790,297 9.900% | -8,765,472 (-6.66%) | Filing |
| 2023-01-31 08:55 am Purchase | 2022-12-31 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 131,555,769 10.500% | 4,623,076 (+3.64%) | Filing |
| 2022-07-08 4:56 pm Purchase | 2022-06-30 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 126,932,693 10.100% | 7,971,487 (+6.70%) | Filing |
| 2022-02-01 5:14 pm Purchase | 2021-12-31 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 118,961,206 9.500% | 7,777,872 (+7.00%) | Filing |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | Gilead Sciences, Inc. GILD | BlackRock Inc. BLK | 111,183,334 8.900% | 4,709,740 (+4.42%) | Filing |